RECURSION PHARMACEUTICALS INC CLAS (RXRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RXRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RXRX | Director | 43 | ["Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute","Professor of Computational Biology and of Stem Cell and Regenerative Biology at Harvard University","Ph.D. in Organismic and Evolutionary Biology from Harvard University","Assistant Professor in the Computational Biology Program at Memorial Sloan-Kettering Cancer Center","Director of the Dana-Farber Cancer Institute Center for Cancer Evolution","Recipient of the Theodosius Dobzhansky Prize","Recipient of the Alice Hamilton Award","Recipient of the Vilcek Prize for Creative Promise in Biomedical Science","Recipient of the 36th Annual AACR Award for Outstanding Achievement in Cancer Research"] | ["Research and Development","Technology"] | 2026 |
Biography sourced from the proxy statement filing.
Franziska Michor, Ph.D., has served as a member of our Board since November 2024. Dr. Michor is the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute and a Professor of Computational Biology and of Stem Cell and Regenerative Biology at Harvard University. Dr. Michor obtained her undergraduate training in mathematics and molecular biology from the University of Vienna, Austria, and her Ph.D. from the Department of Organismic and Evolutionary Biology at Harvard University. Afterwards, she was awarded a fellowship from the Harvard Society of Fellows. From 2007 until 2010, she was an Assistant Professor in the Computational Biology Program at Memorial Sloan-Kettering Cancer Center. Dr. Michor is the director of the Dana-Farber Cancer Institute Center for Cancer Evolution. She has been the recipient of the Theodosius Dobzhansky Prize of the Society for the Study of Evolution, the Alice Hamilton Award, the Vilcek Prize for Creative Promise in Biomedical Science, the 36th Annual AACR Award for Outstanding Achievement in Cancer Research, and others. Dr. Michor s laboratory investigates the evolutionary dynamics of cancer initiation, progression, response to therapy, and emergence of resistance. Our Board believes Dr. Michor is qualified to serve on our Board because of her expertise in oncology and computational biology.